Copyright
©The Author(s) 1999.
World J Gastroenterol. Apr 15, 1999; 5(2): 179-180
Published online Apr 15, 1999. doi: 10.3748/wjg.v5.i2.179
Published online Apr 15, 1999. doi: 10.3748/wjg.v5.i2.179
Group | Incubation day | ||||||
3 | 7 | 10 | 12 | 15 | 17 | 20 | |
TAK | 30.3 | 42.8 | 58.7 | 54.0 | 49.9 | 47.0 | 36.9 |
CD3AK | 25.4 | 39.7 | 47.5 | 50.2 | 38.9 | 38.4 | 27.0 |
LAK | 23.5 | 34.7 | 38.5 | 30.8 | 14.5 | 10.4 | 8.9 |
Incubation | CD3 | CD4 | CD8 | CD4/CD8 | NK | CD19 |
0 d | 52.80 | 49.40 | 26.40 | 1.87 | 23.30 | 7.20 |
10 d | 49.88 | 44.36 | 62.80 | 0.76 | 4.53 | 0.20 |
Group | Stimulated by | Duplication of proliferation | Killing activity |
1 | IL-2 alone | 2.1 | 38.5% |
2 | IL-2 alone after costimulation | 3.8 | 40.1% |
with anti-CD3 mAb for 48 h | |||
3 | Coexistence of anti-CD3 mAb | 5.3 | 58.7% |
and IL-2 during incubation |
- Citation: Chen Q, Ye YB, Chen Z. Activation of killer cells with soluble gastric cancer antigen combined with anti-CD3 McAb. World J Gastroenterol 1999; 5(2): 179-180
- URL: https://www.wjgnet.com/1007-9327/full/v5/i2/179.htm
- DOI: https://dx.doi.org/10.3748/wjg.v5.i2.179